Resources
Videos for clinicians to learn more about Arthrosamid®, a new class of injectable therapy to treat knee osteoarthritis patients.
If you cannot find the content you need here, please contact us.
Hydrogel Arthrosamid® bei Arthrose in den Kniegelenken - ROC Aschheim
Knieosteoarthritis oder Kniearthrose ist die Abnutzung und der Verlust des Gelenkknorpels und die am häufigsten diagnostizierte Art von Arthritis. Neben einer vererbten Neigung zur Arthrose oder bestimmten vererbten Merkmalen, gibt es jedoch mehrere zusätzliche Faktoren, die zu einem erhöhten Risiko für die Entwicklung einer Kniearthrose beitragen können. Als erste Praxis in Deutschland haben wir das neue Polyacrylamid Hydrogel von Arthrosamid® für die Behandlung von Arthrose am Knie verwendet. Es wird bereits seit über 20 Jahren im Pferdesport verwendet und ist seit 2021 auch für Menschen zugelassen. Bei der Behandlung mit Hydrogel Arthrosamid® werden dem/r Patienten/in lediglich 6 ml Hydrogel in das Kniegelenk injiziert.
BASK 2023 Congress - Introducing Arthrosamid® a new class of injectable therapy to treat knee osteoarhritis
The team attended the BASK 2023 Congress to discuss a new injectable class of therapy to treat patients with knee osteoarthritis.
Arthrosamid® is a new type of treatment injected into the knee to help treat the pain caused by knee osteoarthritis, offering an alternative to currently available therapies.
A recent study presented at the OARSI 2023 World Congress has demonstrated that a single injection of 6 ml 2.5% polyacrylamide #hydrogel, Arthrosamid®, maintained a statistically significant reduction in pain in patients with knee osteoarthritis (OA) 3 years after treatment.
BOA 2022 Congress and London Knee Meeting Summary
We attended the BOA2022 Congress and London Knee Meeting this month to introduce Arthrosamid®, a new class of therapy for patients with knee osteoarthritis. the coming month, we will attend the Bristol/Oxford Uni Knee Meeting and Wexham Cruciate 2022.
BASK 2022 - Introducing Arthrosamid®, a new class of injectable therapy to treat knee OA
BOA 2021 - Arthrosamid® by Contura Orthopaedics Ltd - The Knee OA Treatment 20 Years in the Making
Contura Orthopaedics Sponsored Session at BOA 2021 - Presentation on Arthrosamid® by Contura Orthopaedics Ltd - The Knee OA Treatment 20 Years in the Making - Whole Presentation
Dr Ieva Ankorina Stark Hydrogel BOA 2021
Contura Sponsored Session at BOA 2021 - Presentation on Arthrosamid Novel OA Treatment - Product Information
Prof Henning Bliddal BOA 2021
Contura Sponsored Session at BOA 2021 - Presentation on Arthrosamid Novel OA Treatment Clinical Results
Prof Phil Conaghan OARSI 2021
Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Introduction on Intraarticular OA treatments
OARSI 2021 Emerging data on a new class of knee OA therapy
Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Whole Presentation
Dr Ieva Ankorina Stark Hydrogel OARSI 2021
Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Product Information